Pechabou, France

Jean-Pierre Lepargneur

This inventor holds 1 USPTO granted patent. Top assignee: Serbio. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Pierre Lepargneur. Retrieved from https://idiyas.com/inventor/jean-pierre-lepargneur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Pierre Lepargneur

Introduction

Jean-Pierre Lepargneur is a notable inventor based in Pechabou, France. He has made significant contributions to the field of biotechnology, particularly in the identification of pathogens. His work has implications for medical diagnostics and treatment.

Latest Patents

Jean-Pierre holds a patent for a "Process for identifying candida by means of chromogenic substances." This innovative approach enhances the detection of candida, which is crucial for timely medical intervention.

Career Highlights

Jean-Pierre is currently associated with Serbio, a company that focuses on developing advanced diagnostic solutions. His expertise in biotechnology has been instrumental in driving the company's research initiatives.

Collaborations

He has collaborated with notable colleagues, including Genevieve Contant Epouse Pussard and Jean-Luc Martinoli. Their combined efforts have contributed to the advancement of diagnostic technologies.

Conclusion

Jean-Pierre Lepargneur's work exemplifies the impact of innovation in biotechnology. His contributions continue to shape the future of medical diagnostics and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…